Close Menu

Columbia

This story was originally posted on March 29.
By Justin Petrone

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Columbia University's trustees today sued Illumina claiming infringement of five patents covering methods for next-generation sequencing.

Columbia University of New York has received US Patent No. 8,133,492, "Pneumococcus polysaccharide-related vaccines." Nitrocellulose-based or hydrogel-based microarrays and methods of making them are claimed.

By Justin Petrone
Chromosomal microarrays could eventually become the standard of care for prenatal genetic testing in the US if implemented correctly, according to the results of a recent study.

Pages

In a cartoon, Vox explores the lack of women among this year's winners of the Nobel Prize.

Science reports a new US defense bill would establish two groups aimed at combating foreign influence on research. 

Nature Biotechnology discusses promising early results from two clinical trials of CRISPR-based therapy for β-thalassemia and sickle cell disease.

In Cell this week: analysis of tissue clones, metagenomic studies of ocean water samples, and more.